aluates Reports

$ 0.0

Automative

Global Pril-series Drugs Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-22Z16995

BUY CHAPTERS

Global Pril-series Drugs Market Research Report 2024

Code: QYRE-Auto-22Z16995

Report

May 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Servier

Sanofi

Novartis

Bristol Myers Squibb Company

Pfizer Inc

Huahai Pharmaceutical

Shenzhen Salubris Pharmaceuticals

TAD Pharma

Organon Pharma

Kunshan Rotam Reddy Pharmaceutical

Pril-series Drugs Market

Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.

The global Pril-series Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Pril-series Drugs in Hospital Pharmaty is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Pril-series Drugs include Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pril-series Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pril-series Drugs.

The Pril-series Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pril-series Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pril-series Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pril-series Drugs Market Report

Report Metric	Details
Report Name	Pril-series Drugs Market
Segment by Type	Enalapril Lisinopril Captopril Ramipril Perindopril Others
Segment by Application	Hospital Pharmaty Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pril-series Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pril-series Drugs Market report?

Ans: The main players in the Pril-series Drugs Market are Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals

What are the Application segmentation covered in the Pril-series Drugs Market report?

Ans: The Applications covered in the Pril-series Drugs Market report are Hospital Pharmaty, Retail Pharmacy

What are the Type segmentation covered in the Pril-series Drugs Market report?

Ans: The Types covered in the Pril-series Drugs Market report are Enalapril, Lisinopril, Captopril, Ramipril, Perindopril, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pril-series Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Enalapril

1.2.3 Lisinopril

1.2.4 Captopril

1.2.5 Ramipril

1.2.6 Perindopril

1.2.7 Others

1.3 Market by Application

1.3.1 Global Pril-series Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmaty

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pril-series Drugs Market Perspective (2019-2030)

2.2 Global Pril-series Drugs Growth Trends by Region

2.2.1 Global Pril-series Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pril-series Drugs Historic Market Size by Region (2019-2024)

2.2.3 Pril-series Drugs Forecasted Market Size by Region (2025-2030)

2.3 Pril-series Drugs Market Dynamics

2.3.1 Pril-series Drugs Industry Trends

2.3.2 Pril-series Drugs Market Drivers

2.3.3 Pril-series Drugs Market Challenges

2.3.4 Pril-series Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pril-series Drugs Players by Revenue

3.1.1 Global Top Pril-series Drugs Players by Revenue (2019-2024)

3.1.2 Global Pril-series Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Pril-series Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pril-series Drugs Revenue

3.4 Global Pril-series Drugs Market Concentration Ratio

3.4.1 Global Pril-series Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pril-series Drugs Revenue in 2023

3.5 Global Key Players of Pril-series Drugs Head office and Area Served

3.6 Global Key Players of Pril-series Drugs, Product and Application

3.7 Global Key Players of Pril-series Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pril-series Drugs Breakdown Data by Type

4.1 Global Pril-series Drugs Historic Market Size by Type (2019-2024)

4.2 Global Pril-series Drugs Forecasted Market Size by Type (2025-2030)

5 Pril-series Drugs Breakdown Data by Application

5.1 Global Pril-series Drugs Historic Market Size by Application (2019-2024)

5.2 Global Pril-series Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pril-series Drugs Market Size (2019-2030)

6.2 North America Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pril-series Drugs Market Size by Country (2019-2024)

6.4 North America Pril-series Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pril-series Drugs Market Size (2019-2030)

7.2 Europe Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pril-series Drugs Market Size by Country (2019-2024)

7.4 Europe Pril-series Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pril-series Drugs Market Size (2019-2030)

8.2 Asia-Pacific Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pril-series Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Pril-series Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pril-series Drugs Market Size (2019-2030)

9.2 Latin America Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pril-series Drugs Market Size by Country (2019-2024)

9.4 Latin America Pril-series Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pril-series Drugs Market Size (2019-2030)

10.2 Middle East & Africa Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pril-series Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Pril-series Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Servier

11.1.1 Servier Company Details

11.1.2 Servier Business Overview

11.1.3 Servier Pril-series Drugs Introduction

11.1.4 Servier Revenue in Pril-series Drugs Business (2019-2024)

11.1.5 Servier Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Pril-series Drugs Introduction

11.2.4 Sanofi Revenue in Pril-series Drugs Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Pril-series Drugs Introduction

11.3.4 Novartis Revenue in Pril-series Drugs Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Pril-series Drugs Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (2019-2024)

11.4.5 Bristol-Myers Squibb Company Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Pril-series Drugs Introduction

11.5.4 Pfizer Revenue in Pril-series Drugs Business (2019-2024)

11.5.5 Pfizer Recent Development

11.6 TAD Pharma

11.6.1 TAD Pharma Company Details

11.6.2 TAD Pharma Business Overview

11.6.3 TAD Pharma Pril-series Drugs Introduction

11.6.4 TAD Pharma Revenue in Pril-series Drugs Business (2019-2024)

11.6.5 TAD Pharma Recent Development

11.7 Organon Pharma

11.7.1 Organon Pharma Company Details

11.7.2 Organon Pharma Business Overview

11.7.3 Organon Pharma Pril-series Drugs Introduction

11.7.4 Organon Pharma Revenue in Pril-series Drugs Business (2019-2024)

11.7.5 Organon Pharma Recent Development

11.8 Huahai Pharmaceutical

11.8.1 Huahai Pharmaceutical Company Details

11.8.2 Huahai Pharmaceutical Business Overview

11.8.3 Huahai Pharmaceutical Pril-series Drugs Introduction

11.8.4 Huahai Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024)

11.8.5 Huahai Pharmaceutical Recent Development

11.9 Kunshan Rotam Reddy Pharmaceutical

11.9.1 Kunshan Rotam Reddy Pharmaceutical Company Details

11.9.2 Kunshan Rotam Reddy Pharmaceutical Business Overview

11.9.3 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Introduction

11.9.4 Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024)

11.9.5 Kunshan Rotam Reddy Pharmaceutical Recent Development

11.10 Shenzhen Salubris Pharmaceuticals

11.10.1 Shenzhen Salubris Pharmaceuticals Company Details

11.10.2 Shenzhen Salubris Pharmaceuticals Business Overview

11.10.3 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Introduction

11.10.4 Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (2019-2024)

11.10.5 Shenzhen Salubris Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Servier

Sanofi

Novartis

Bristol Myers Squibb Company

Pfizer Inc

Huahai Pharmaceutical

Shenzhen Salubris Pharmaceuticals

TAD Pharma

Organon Pharma

Kunshan Rotam Reddy Pharmaceutical

List of Tables

Table 1. Global Pril-series Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Enalapril

Table 3. Key Players of Lisinopril

Table 4. Key Players of Captopril

Table 5. Key Players of Ramipril

Table 6. Key Players of Perindopril

Table 7. Key Players of Others

Table 8. Global Pril-series Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Pril-series Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Pril-series Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Pril-series Drugs Market Share by Region (2019-2024)

Table 12. Global Pril-series Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Pril-series Drugs Market Share by Region (2025-2030)

Table 14. Pril-series Drugs Market Trends

Table 15. Pril-series Drugs Market Drivers

Table 16. Pril-series Drugs Market Challenges

Table 17. Pril-series Drugs Market Restraints

Table 18. Global Pril-series Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Pril-series Drugs Market Share by Players (2019-2024)

Table 20. Global Top Pril-series Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pril-series Drugs as of 2023)

Table 21. Ranking of Global Top Pril-series Drugs Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Pril-series Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Pril-series Drugs, Headquarters and Area Served

Table 24. Global Key Players of Pril-series Drugs, Product and Application

Table 25. Global Key Players of Pril-series Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pril-series Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Pril-series Drugs Revenue Market Share by Type (2019-2024)

Table 29. Global Pril-series Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Pril-series Drugs Revenue Market Share by Type (2025-2030)

Table 31. Global Pril-series Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Pril-series Drugs Revenue Market Share by Application (2019-2024)

Table 33. Global Pril-series Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Pril-series Drugs Revenue Market Share by Application (2025-2030)

Table 35. North America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Pril-series Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Pril-series Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 50. Servier Company Details

Table 51. Servier Business Overview

Table 52. Servier Pril-series Drugs Product

Table 53. Servier Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 54. Servier Recent Development

Table 55. Sanofi Company Details

Table 56. Sanofi Business Overview

Table 57. Sanofi Pril-series Drugs Product

Table 58. Sanofi Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 59. Sanofi Recent Development

Table 60. Novartis Company Details

Table 61. Novartis Business Overview

Table 62. Novartis Pril-series Drugs Product

Table 63. Novartis Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 64. Novartis Recent Development

Table 65. Bristol-Myers Squibb Company Company Details

Table 66. Bristol-Myers Squibb Company Business Overview

Table 67. Bristol-Myers Squibb Company Pril-series Drugs Product

Table 68. Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 69. Bristol-Myers Squibb Company Recent Development

Table 70. Pfizer Company Details

Table 71. Pfizer Business Overview

Table 72. Pfizer Pril-series Drugs Product

Table 73. Pfizer Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 74. Pfizer Recent Development

Table 75. TAD Pharma Company Details

Table 76. TAD Pharma Business Overview

Table 77. TAD Pharma Pril-series Drugs Product

Table 78. TAD Pharma Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 79. TAD Pharma Recent Development

Table 80. Organon Pharma Company Details

Table 81. Organon Pharma Business Overview

Table 82. Organon Pharma Pril-series Drugs Product

Table 83. Organon Pharma Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 84. Organon Pharma Recent Development

Table 85. Huahai Pharmaceutical Company Details

Table 86. Huahai Pharmaceutical Business Overview

Table 87. Huahai Pharmaceutical Pril-series Drugs Product

Table 88. Huahai Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 89. Huahai Pharmaceutical Recent Development

Table 90. Kunshan Rotam Reddy Pharmaceutical Company Details

Table 91. Kunshan Rotam Reddy Pharmaceutical Business Overview

Table 92. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product

Table 93. Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 94. Kunshan Rotam Reddy Pharmaceutical Recent Development

Table 95. Shenzhen Salubris Pharmaceuticals Company Details

Table 96. Shenzhen Salubris Pharmaceuticals Business Overview

Table 97. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product

Table 98. Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)

Table 99. Shenzhen Salubris Pharmaceuticals Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Pril-series Drugs Picture

Figure 2. Global Pril-series Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pril-series Drugs Market Share by Type: 2023 VS 2030

Figure 4. Enalapril Features

Figure 5. Lisinopril Features

Figure 6. Captopril Features

Figure 7. Ramipril Features

Figure 8. Perindopril Features

Figure 9. Others Features

Figure 10. Global Pril-series Drugs Market Size by Application (2024-2030) & (US$ Million)

Figure 11. Global Pril-series Drugs Market Share by Application: 2023 VS 2030

Figure 12. Hospital Pharmaty Case Studies

Figure 13. Retail Pharmacy Case Studies

Figure 14. Pril-series Drugs Report Years Considered

Figure 15. Global Pril-series Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Pril-series Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Pril-series Drugs Market Share by Region: 2023 VS 2030

Figure 18. Global Pril-series Drugs Market Share by Players in 2023

Figure 19. Global Top Pril-series Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pril-series Drugs as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Pril-series Drugs Revenue in 2023

Figure 21. North America Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Pril-series Drugs Market Share by Country (2019-2030)

Figure 23. United States Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Pril-series Drugs Market Share by Country (2019-2030)

Figure 27. Germany Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Pril-series Drugs Market Share by Region (2019-2030)

Figure 35. China Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Pril-series Drugs Market Share by Country (2019-2030)

Figure 43. Mexico Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Pril-series Drugs Market Share by Country (2019-2030)

Figure 47. Turkey Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. UAE Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Servier Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 54. Pfizer Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 55. TAD Pharma Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 56. Organon Pharma Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 57. Huahai Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 58. Kunshan Rotam Reddy Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 59. Shenzhen Salubris Pharmaceuticals Revenue Growth Rate in Pril-series Drugs Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Perindopril tert Butylamine Tablets Market Research Report 2024

Global Enalapril Maleate Market Research Report 2024

Global Antihypertensive Drugs Market Research Report 2024

Global Renin Inhibitors Market Research Report 2025

Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024

Angiotensin Converting Enzyme ACE Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ramipril API Market Research Report 2025

Global Perindopril Erbumine API Market Research Report 2024

Angiotensin Converting Enzyme Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enalapril Market Research Report 2024

Global Sartan series Drugs Market Research Report 2024

Global Fosinopril Sodium Tablets Market Research Report 2024

Global Enalaprilat Market Research Report 2024

Propranolol Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Propranolol Market

Prilide Antihypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enalapril Maleate API Market Research Report 2024

Propranolol Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions